| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fennec Pharmaceuticals Inc. (FENC) has 8 insiders with recent SEC Form 4 filings, including 85 buys and 31 sells. FENC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.74M | $24.70M | - | |
| CFO | 289.3K | $2.60M | - | |
| Dir | 139.8K | $1.26M | -9,747 | |
| CEO | 62.8K | $565.4K | - | |
| Dir | 58.9K | $529.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 4, 2020 | Southpoint Capital Advisors LP62 | 10% Owner | Buy | 80,000 | $6.25 | $500,000.00 | +2.0% | |
| Apr 30, 2020 | Essetifin Spa | 10% Owner | Buy | 768,000 | $6.25 | $4,800,000.00 | +23.8% | |
| Mar 28, 2018 | Manchester Management Pr, LLC | 10% Owner | Sell | 914,745 | $10.61 | $9,704,023.36 | -2.0% | |
| Mar 6, 2018 | Manchester Management Pr, LLC | 10% Owner | Sell | 70,100 | $9.22 | $646,577.00 | -0.7% | |
| Dec 12, 2017 | Essetifin Spa | 10% Owner | Buy | 294,115 | $8.50 | $2,499,977.50 | +10.0% | |
| Oct 24, 2017 | Manchester Management Pr, LLC | 10% Owner | Buy | 79,830 | $7.28 | $581,309.80 | +0.2% | |
| Dec 30, 2016 | Manchester Management Pr, LLC | 10% Owner | Buy | 96,000 | $2.01 | $192,640.00 | +0.2% | |
| Aug 4, 2016 | Manchester Management Pr, LLC | 10% Owner | Buy | 190,850 | $2.06 | $392,528.00 | +0.4% |